Clinical Outcomes of Boston Type 1 Keratoprosthesis with and without Endophthalmitis During the Covid-19 Pandemic
This KPro cohort, with 67% of patients presenting during the COVID-19 pandemic, had a higher rate of endophthalmitis than previously reported in the literature. Black patients had a higher risk of getting endophthalmitis than White patients. BCL usage appeared to have a protective effect against endophthalmitis, while neither post-operative antibiotic use nor vitrectomy had a significant effect on rates of endophthalmitis.
Authors
- Talia R. Kaden (ORCID: https://orcid.org/0000-0001-6945-7664)
- Meera S. Ramakrishnan (ORCID: https://orcid.org/0000-0002-8832-5285)
- John A. Seedor
- Andrew Tirsi (ORCID: https://orcid.org/0000-0002-8424-7574)
- David C. Ritterband (ORCID: https://orcid.org/0000-0001-7139-878X)
- Daniel Zhu (ORCID: https://orcid.org/0000-0001-6569-9623)
- Richard Adamovich‐Zeitlin
- Elmira Baghdasaryan (ORCID: https://orcid.org/0000-0002-3010-7437)
- Isha Cheela (ORCID: https://orcid.org/0000-0003-4535-8914)
- William M. Schiff
- Gaetano R. Barile
Institutions
- Northwell Health (US)
- Montefiore Medical Center (US)
- Hofstra University (US)
- Manhattan Eye, Ear and Throat Hospital (US)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1080/09273948.2025.2562357
- Citations
- 1
- Primary Topic
- Corneal Surgery and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.36